Sophia Genetics SAS
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Predictive Multimodal Signatures Associated With Response to Treatment and Prognosis of Patients With Stage IV Non-small Cell Lung Cancer (NCT04994795) | Sophia Genetics SAS | 2021-08-21 |
Track Sophia Genetics SAS automatically
Every clearance here is in the API, with alerts when new ones post.